Juliane Tetzlaff1, Denise Muschik2, Jelena Epping2, Sveja Eberhard3, Siegfried Geyer2. 1. Medical Sociology Unit, Hannover Medical School, Hanover, Germany. Tetzlaff.Juliane@mh-hannover.de. 2. Medical Sociology Unit, Hannover Medical School, Hanover, Germany. 3. AOK Niedersachsen-Statutory Health Insurance of Lower Saxony, Hanover, Germany.
Abstract
OBJECTIVES: Our study examined how life years spent in multimorbidity changed over a period of 10 years (2005-2014) and whether morbidity expansion or compression has taken place. There is a little evidence on whether life years gained due to increasing life expectancy are spent in good health, or if they are accompanied by morbidity expansion. METHODS: The analyses are based on German administrative claims data. Multimorbidity was defined as a combination of at least six chronic conditions and polypharmacy. After having estimated age-standardized prevalence, time trends for life years with and without multimorbidity, and the proportion of life years spent in multimorbidity (morbidity ratio) were estimated. RESULTS: Prevalence proportions of multimorbidity rose continuously. Increasing life expectancies were accompanied by increasing life years with multimorbidity, decreasing multimorbidity-free life years, and by an increasing morbidity ratio. CONCLUSIONS: The lifespan spent in multimorbidity was increasing over time. Our findings indicate a growing burden of multimorbidity and an increasing proportion of life years with multiple chronic conditions. It can be concluded that an expansion of morbidity in absolute and in relative terms has occurred. The findings stress the importance of prevention, healthy lifestyles, and improved medical care strategies meeting the specific requirements of patients with multimorbidity.
OBJECTIVES: Our study examined how life years spent in multimorbidity changed over a period of 10 years (2005-2014) and whether morbidity expansion or compression has taken place. There is a little evidence on whether life years gained due to increasing life expectancy are spent in good health, or if they are accompanied by morbidity expansion. METHODS: The analyses are based on German administrative claims data. Multimorbidity was defined as a combination of at least six chronic conditions and polypharmacy. After having estimated age-standardized prevalence, time trends for life years with and without multimorbidity, and the proportion of life years spent in multimorbidity (morbidity ratio) were estimated. RESULTS: Prevalence proportions of multimorbidity rose continuously. Increasing life expectancies were accompanied by increasing life years with multimorbidity, decreasing multimorbidity-free life years, and by an increasing morbidity ratio. CONCLUSIONS: The lifespan spent in multimorbidity was increasing over time. Our findings indicate a growing burden of multimorbidity and an increasing proportion of life years with multiple chronic conditions. It can be concluded that an expansion of morbidity in absolute and in relative terms has occurred. The findings stress the importance of prevention, healthy lifestyles, and improved medical care strategies meeting the specific requirements of patients with multimorbidity.
Entities:
Keywords:
Compression; Expansion; Multimorbidity; Prevalence; Time trend
Authors: Bernard Jeune; Mette Lindholm Eriksen; Karen Andersen-Ranberg; Henrik Brønnum-Hansen Journal: Scand J Public Health Date: 2015-02-23 Impact factor: 3.021
Authors: Eliza F Chakravarty; Helen B Hubert; Eswar Krishnan; Bonnie B Bruce; Vijaya B Lingala; James F Fries Journal: Am J Med Date: 2012-02 Impact factor: 4.965
Authors: Seppo T Rinne; Edwin S Wong; Jaclyn M Lemon; Mark Perkins; Christopher L Bryson; Chuan-Fen Liu Journal: Am J Manag Care Date: 2015-01-01 Impact factor: 2.229
Authors: Nafeesa N Dhalwani; Gary O'Donovan; Francesco Zaccardi; Mark Hamer; Thomas Yates; Melanie Davies; Kamlesh Khunti Journal: Int J Behav Nutr Phys Act Date: 2016-01-19 Impact factor: 6.457
Authors: Bettina Meinow; Peng Li; Domantas Jasilionis; Anna Oksuzyan; Louise Sundberg; Susanne Kelfve; Jonas W Wastesson Journal: BMC Public Health Date: 2022-04-14 Impact factor: 4.135
Authors: Siegfried Geyer; Sveja Eberhard; Bernhard Magnus W Schmidt; Jelena Epping; Juliane Tetzlaff Journal: PLoS One Date: 2018-08-23 Impact factor: 3.240
Authors: Juliane Tetzlaff; Jelena Epping; Stefanie Sperlich; Sveja Eberhard; Jona Theodor Stahmeyer; Siegfried Geyer Journal: Int J Equity Health Date: 2018-07-16